Associated Factors With Antipsychotic Use in Long-Term Institutional Care in Eight European Countries: Results From the RightTimePlaceCare Study.

Adelaide de Mauleon, Sandrine Sourdet, Anna Renom-Guiteras, Sophie Gillette-Guyonnet, Helena Leino-Kilpi, Staffan Karlsson, Michel Bleijlevens, Adela Zabategui, Kai Saks, Bruno Vellas, David Jolley, Maria Soto

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

    29 Citeringar (SciVal)

    Sammanfattning

    To determine factors associated with the antipsychotic (AP) prescription for people with dementia (PwD) recently admitted to institutional long-term care facilities (LTCFs) and to ascertain differences in the use of this medication in 8 European countries.
    Originalspråkengelska
    Sidor (från-till)812-818
    TidskriftJournal of the American Medical Directors Association
    Volym15
    Utgåva11
    DOI
    StatusPublished - 2014

    Ämnesklassifikation (UKÄ)

    • Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi

    Fingeravtryck

    Utforska forskningsämnen för ”Associated Factors With Antipsychotic Use in Long-Term Institutional Care in Eight European Countries: Results From the RightTimePlaceCare Study.”. Tillsammans bildar de ett unikt fingeravtryck.

    Citera det här